Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT
- 6 August 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 35 (10), 1912-1920
- https://doi.org/10.1007/s00259-008-0890-2
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histologyNuclear Medicine Communications, 2007
- The diagnostic value of PET/CT for primary ovarian cancer—A prospective studyGynecologic Oncology, 2007
- Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodesGynecologic Oncology, 2005
- Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancerGynecologic Oncology, 2005
- Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PETJournal of Clinical Oncology, 2004
- Ovarian cancer in the elderlyCritical Reviews in Oncology/Hematology, 2004
- Preoperative Diagnosis of Ovarian Tumors with MR ImagingAmerican Journal of Roentgenology, 2001
- Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaThe Lancet, 2001
- Classification of Asymptomatic Adnexal Masses by Ultrasound, Magnetic Resonance Imaging, and Positron Emission TomographyGynecologic Oncology, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996